Extinction Pharmaceuticals, Inc. is a drug development company with a proprietary and revolutionary therapeutic approach.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Williamsburg
State: Virginia
Zip:
Country: United States
Extinction Pharmaceuticals, Inc. is a drug development company with a proprietary and revolutionary therapeutic approach (i.e., administering D-cycloserine in conjunction with therapy) for treating anxiety disorders and other afflictions that can benefit from traditional talk therapy treatments. Fundamentally, their drug works by consolidating the learning from a therapy session, thereby making therapy sessions more efficient. This effect has been demonstrated in placebo-controlled, double-blind human clinical trials for panic disorder, social anxiety disorder, obsessive-compulsive disorder, and simple phobia, and is currently being tested in investigator-initiated clinical trials for addiction, autism, stroke recovery, and other conditions.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2011 | Seed Round | 1 | - |
Virginia Venture Partners Virginia Venture Partners |
3/2011 | Seed Round | 1 | - |
Virginia Venture Partners Virginia Venture Partners |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|